Navigation Links
Migenix Takes Operational Actions To Extend Cash Past Upcoming Key Milestones
Date:5/27/2008

VANCOUVER and SAN DIEGO, May 27 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI, OTC: MGIFF), a clinical-stage developer of drugs for infectious diseases, is taking aggressive steps to further reduce expenses to extend its cash runway through the Omigard(TM) Phase III results milestone expected in the second half of 2008 while continuing to focus on advancing the Company's MX-2401 program. Efforts are also underway to raise additional cash which will be required to enable continued key development activities expected to maximize long-term shareholder value and extend the Company's cash position into 2009.

The cost reduction actions include some limited program-related changes, substantial management and board compensation cuts, personnel reductions, and other operational streamlining activities (see "SPECIFIC COST-CUTTING ACTIONS" below).

Jim DeMesa, M.D., President and CEO of MIGENIX stated, "We must preserve our cash during this very difficult financial market for biotech companies. With the significant value-driving milestones we expect during the second half of this year and the first half of next year - along with the potential start of Omigard(TM) related revenues - we must take these actions to extend our cash runway as long as possible while continuing to advance our greatest product opportunities. These actions are expected to achieve both. All of us at MIGENIX are committed to creating value for our shareholders, advancing our pipeline of promising drug candidates and improving lives."

As a result of these initiatives, the following are our potential milestones over the next 12 months:

Omigard(TM) (prevention of catheter-related infections):

--------------------------------------------------------

- Positive Phase III results in H2/08

- NDA submission in H1/09, with the associated milestone payments

- Completion of rest of world partnership(s), with associated up-front

paymen
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
2. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
3. MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
4. MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
5. MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
6. MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results
7. MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study
8. MIGENIX releases CEO message #22
9. MIGENIX Third Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
10. MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results
11. MIGENIX Appoints Pieter Dorsman to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 ... http://www.researchandmarkets.com/research/cmbgcv/north_american ) has announced the addition ... Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET ... (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & ... report to their offering. ...
(Date:6/18/2013)... New user friendly innovations in table ... the dangers of misuse and ineffective sterilization. Older ... gauges, hot surfaces and complex door latches. Whether ... autoclave, Revolutionary Science explains some important points to remember. ... designs will recycle dirty water. This method can ...
(Date:6/18/2013)... 2013 ActiGraph, a leading provider of ... global research community, announced today that Dr. Victor KR ... is the Scientific Director of the Physical Fitness Research ... of Medicine at Gama Filho University and the Chairman ... State Secretariat of Health of São Paulo State, Brazil. ...
(Date:6/18/2013)... 18, 2013 Kitware , a ... a new Fast-Track award from the U.S. Department of ... (IDAE) for the nuclear power industry. , Construction of ... than 30 years, but the United States’ nuclear power ... in power plant utilization through improved refueling, maintenance, and ...
Breaking Biology Technology:North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 2North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 3How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2Dr. Victor KR Matsudo Joins ActiGraph Scientific Advisory Board 2Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2
... - The nation's fifth largest school district is being ... Johnson Controls, Inc. , to deter sexual predators from ... its attempts to develop hybrid car batteries and energy-efficient ... next month, utilizing digital identification checkpoints in 250 ...
... M ilwaukee, Wis. - Teresa Esser ... Wisconsin and, as the new director of the Milwaukee-based ... to see more of that opportunity realized. , ,While ... of capital in Wisconsin, particularly in the tech sector, ...
... a modest renewable fuel standard contained in the Energy ... and Congressman Ron Kind have called for a ... appearance at the Farmers Cooperative Shipping and Supply Association, Doyle ... the RFS, and they touted the economic and energy independence ...
Cached Biology Technology:Florida schools employ Johnson Controls technology to stop sex predators 2New Silicon Pastures director envisions more home cooking for Wisconsin angels 2New Silicon Pastures director envisions more home cooking for Wisconsin angels 3New Silicon Pastures director envisions more home cooking for Wisconsin angels 4New Silicon Pastures director envisions more home cooking for Wisconsin angels 5New Silicon Pastures director envisions more home cooking for Wisconsin angels 6Doyle, Kind call for higher renewable fuel standard 2Doyle, Kind call for higher renewable fuel standard 3
(Date:6/17/2013)... Kansas State University research associate has received a prestigious ... to prevent the spread of malaria. , Bart Bryant, ... of Health,s National Research Service Award Individual Postdoctoral Fellowship, ... seventh Kansas State University researcher to receive the award ... hold such an award. , Bryant, a university doctoral ...
(Date:6/17/2013)... method of mining shale gas, is widespread across Pennsylvania, ... New research in the Annals of the New ... to biodiversity including pollution from toxic chemicals, the building ... , "Shale gas has engendered a great deal of ... but effects on biological diversity and resources have scarcely ...
(Date:6/16/2013)... A mechanism that cells use to group together and move ... been described for the first time by scientists at UCL. ... new study focuses on the process that occurs when cancer ... the body during metastasis. Scientists know that cancer cells recruit ... how this process takes place and how it could be ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2'Chase and run' cell movement mechanism explains process of metastasis 2
... moderate to severe chest pains (angina) who have not ... gene therapy approach being used by cardiologists at Rush ... the heart. , The phase II clinical research study ... of a solution containing a DNA plasmid that is ...
... Implanted devices intended to optimize the cardiac function of ... which patients might be at higher risk of dying ... University Medical Center. , Besides maintaining optimal electrical stimulation ... defibrillation) devices are giving cardiologists a new view of ...
... has used gene therapy in two separate studies to ... and rats with a drug-induced form of Parkinson's disease. ... Brain and The Journal of Neuroscience, essentially describes one ... another strategy to treat the devastating side effects that ...
Cached Biology News:Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments 2Implanted Devices Detect High-Risk Heart Failure Patients 2Implanted Devices Detect High-Risk Heart Failure Patients 3Gene therapy for Parkinson's disease moves forward in animals 2Gene therapy for Parkinson's disease moves forward in animals 3Gene therapy for Parkinson's disease moves forward in animals 4
... 'The DNAscope V is a ... microarray scanning and image processing that deliver ... V is a high quality microarray scanner ... imaging technology for optimal background rejection and ...
... Phospho-Specific(Thr 222 ) ... 10 mM sodium HEPES, 100 ... 7.5. Recognizes the ~47 kDa ... (MAPKAPK-2) protein phosphorylated at Thr ...
Anti-Src-Like Adaptor Protein-2 AVOID FREEZE/THAW CYCLES. Recognizes the ~25 and ~28 kDa forms SLAP-2....
Goat polyclonal to Centaurin alpha 2**...
Biology Products: